NanOlogy Chief Medical Officer on Panel to Discuss Next Wave of Innovation in IO Therapy at BIO CEO & Investor Conference
FT. WORTH, Texas--(BUSINESS WIRE)--Feb 5, 2019--NanOlogy, a clinical-stage oncology company, announced today its Chief Medical Officer, Gere diZerega, MD, will participate on an im…
